Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,113–3,120 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Omeros Corporation Zaltenibart - (OMS906) Paroxysmal nocturnal hemoglobinuria (PNH) Phase 3 Enrollment Initiation Intravenous Hematology
Omeros Corporation Narsoplimab (I-SPY COVID-19) COVID-19 Phase 2 Trial Discontinued Intravenous COVID-19
OmniAb Inc. Batoclimab (IMVT-1401) Myasthenia Gravis (MG) Phase 3 Data Released Subcutaneous Neurology
OmniAb Inc. Batoclimab Graves' Disease Phase 3 Trial Planned Intravenous Endocrinology
OmniAb Inc. Batoclimab (IMVT-1401) Myasthenia Gravis (MG) Phase 3 Data Released Subcutaneous Neurology
OmniAb Inc. Batoclimab Thyroid Eye Disease (TED) Phase 3 Ongoing Intravenous Opthalmic
Oncolytics Biotech Inc. Pelareorep and retifanlimab (INCMGA00012) - (IRENE) Triple-negative breast cancer Phase 2 Trial Completed Intravenous Oncology
Oncolytics Biotech Inc. Pelareorep, (Taxol) paclitaxel and BAVENCIO (avelumab) - (BRACELET-1) HR+ / HER2- breast cancer Phase 2 Data Released Intravenous Oncology